An Unbiased Evaluation of CK2 Inhibitors by ChemoproteomicsJames S. Duncan, David W. Litchfield|Molecular & Cellular Proteomics|2008Cited by 89
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsJonathan Chernoff, James S. Duncan|Research Square|2023Cited by 1